VALLEY NATIONAL ADVISERS INC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
VALLEY NATIONAL ADVISERS INC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,00030.0%0.00%
Q4 2020$030.0%0.00%
Q3 2020$030.0%0.00%
Q2 2020$030.0%0.00%
Q1 2020$030.0%0.00%
Q4 2019$030.0%0.00%
Q3 2019$0
-100.0%
30.0%0.00%
Q2 2019$1,0000.0%30.0%0.00%
Q1 2019$1,00030.0%0.00%
Q4 2018$0
-100.0%
30.0%0.00%
Q3 2018$1,00030.0%0.00%
Q2 2018$030.0%0.00%
Q1 2018$030.0%0.00%
Q4 2017$030.0%0.00%
Q3 2017$030.0%0.00%
Q2 2017$030.0%0.00%
Q1 2017$030.0%0.00%
Q4 2016$030.0%0.00%
Q3 2016$030.0%0.00%
Q2 2016$030.0%0.00%
Q1 2016$030.0%0.00%
Q4 2015$030.0%0.00%
Q3 2015$030.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders